[go: up one dir, main page]

HK1000697A1 - Use of droloxifene for the treatment of cardiovascular diseases - Google Patents

Use of droloxifene for the treatment of cardiovascular diseases Download PDF

Info

Publication number
HK1000697A1
HK1000697A1 HK97102010A HK97102010A HK1000697A1 HK 1000697 A1 HK1000697 A1 HK 1000697A1 HK 97102010 A HK97102010 A HK 97102010A HK 97102010 A HK97102010 A HK 97102010A HK 1000697 A1 HK1000697 A1 HK 1000697A1
Authority
HK
Hong Kong
Prior art keywords
droloxifene
citrate
treatment
acid
cardiovascular diseases
Prior art date
Application number
HK97102010A
Other languages
English (en)
Chinese (zh)
Other versions
HK1000697B (zh
Inventor
罗兰‧洛瑟
迈克尔‧施里埃克
戴维‧D‧汤普森
Original Assignee
美国辉瑞有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 美国辉瑞有限公司 filed Critical 美国辉瑞有限公司
Publication of HK1000697A1 publication Critical patent/HK1000697A1/xx
Publication of HK1000697B publication Critical patent/HK1000697B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
HK97102010.6A 1994-07-19 1995-05-26 使用屈洛昔芬治療心血管疾病 HK1000697B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/276,969 US5441986A (en) 1994-07-19 1994-07-19 Estrogen agonists as remedies for prostate and cardiovascular diseases
US08/276,969 1994-07-19
PCT/IB1995/000403 WO1996002242A1 (en) 1994-07-19 1995-05-26 Use of droloxifene for the treatment of cardiovascular diseases

Publications (2)

Publication Number Publication Date
HK1000697A1 true HK1000697A1 (en) 2002-05-10
HK1000697B HK1000697B (zh) 2002-05-10

Family

ID=

Also Published As

Publication number Publication date
AU2417095A (en) 1996-02-16
CA2195093A1 (en) 1996-02-01
CN1152868A (zh) 1997-06-25
EP0769941A1 (en) 1997-05-02
KR970704429A (ko) 1997-09-06
KR100221854B1 (ko) 1999-09-15
FI970214A7 (fi) 1997-01-17
FI970215L (fi) 1997-01-17
EP0771194A1 (en) 1997-05-07
AU694220B2 (en) 1998-07-16
US5852059A (en) 1998-12-22
IL114586A (en) 2000-06-29
AU2416995A (en) 1996-02-16
HU9700162D0 (en) 1997-03-28
HUT77391A (hu) 1998-04-28
US5827892A (en) 1998-10-27
EP1029540A3 (en) 2001-05-16
KR100212352B1 (ko) 1999-08-02
FI970214A0 (fi) 1997-01-17
HU9700163D0 (en) 1997-03-28
EP1029540A2 (en) 2000-08-23
CA2195093C (en) 2000-03-07
IL114585A (en) 2000-01-31
NZ285158A (en) 2000-07-28
IL114586A0 (en) 1995-11-27
FI970215A0 (fi) 1997-01-17
KR970704430A (ko) 1997-09-06
HUT77392A (hu) 1998-04-28
FI970215A7 (fi) 1997-01-17
TW403649B (en) 2000-09-01
CA2195213C (en) 2000-03-14
CA2195213A1 (en) 1996-02-01
ZA955963B (en) 1997-01-20
FI970214L (fi) 1997-01-17
MX9700538A (es) 1997-04-30
JPH09507859A (ja) 1997-08-12
MY113079A (en) 2001-11-30
CN1153473A (zh) 1997-07-02
CN1076967C (zh) 2002-01-02
IL114585A0 (en) 1995-11-27
JP2930424B2 (ja) 1999-08-03
MX9700534A (es) 1997-04-30
WO1996002243A1 (en) 1996-02-01
WO1996002242A1 (en) 1996-02-01
NZ285159A (en) 2000-10-27
US5441986A (en) 1995-08-15
ZA955964B (en) 1997-01-20
JPH09507860A (ja) 1997-08-12
AU689257B2 (en) 1998-03-26
US5902830A (en) 1999-05-11

Similar Documents

Publication Publication Date Title
CN1076967C (zh) 使用屈洛昔芬治疗心血管疾病
US4775660A (en) Treatment of breast cancer by combination therapy
US4666885A (en) Combination therapy for treatment of female breast cancer
US4895715A (en) Method of treating gynecomastia
JPH07215871A (ja) 血清コレステロールを減少させるための方法
CN1142767A (zh) 2，3-二芳基-1-苯丙吡喃衍生物在生产治疗和预防骨损失和骨质疏松症药物中的用途
MXPA01010904A (es) Utilizacion del saredutant y de sus sales farmaceuticamente aceptables para la preparacion de medicamentos utiles en el tratamiento o la prevencion del conjunto de los trastornos del humor, de los trastornos de adaptacion o de los trastornos mixtos a
HK1000697B (zh) 使用屈洛昔芬治療心血管疾病
SK18792000A3 (sk) Spôsoby zvýšenia hladín acetylcholínu
AU709606B2 (en) Use of droloxifene for the treatment of prostatic diseases endometriosis and obesity
JP2657614B2 (ja) アロマターゼ阻害剤
KR20010052892A (ko) 아세틸콜린 수치를 상승시키는 방법
US20010041745A1 (en) Methods for increasing levels of acetylcholine
EP0597415B1 (en) Iron therapy using Saccharose octasulfate ferric complex
AU7993998A (en) Droloxifene for prevention of breast cancer
CA1278748C (en) Pharmaceutical composition for combination therapy of hormone dependent cancers
CZ20004699A3 (cs) Způsoby zvyšování hladiny acetylcholinu

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20050526